TERMINAL ILEITIS

This adverse event was reported 614 times

These drugs are most commonly taken by patients reporting TERMINAL ILEITIS:

# Drug Count
0 ADALIMUMAB 192
1 ADALIMUMAB-ADAZ 123
2 ADALIMUMAB-AATY 118
3 ADALIMUMAB-FKJP 117
4 VEDOLIZUMAB 97
5 AZATHIOPRINE 96
6 PREDNISONE 85
7 USTEKINUMAB 82
8 METHOTREXATE SODIUM 80
9 INFLIXIMAB 73
See all common drugs associated with TERMINAL ILEITIS

TERMINAL ILEITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 USTEKINUMAB-AUUB 1 0.0057
1 SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID 3 0.0041
2 FIDAXOMICIN 8 0.0033
3 ADALIMUMAB-FKJP 117 0.0025
4 FOSNETUPITANT AND PALONOSETRON 3 0.0025
5 NETUPITANT AND PALONOSETRON 3 0.0025
6 ADALIMUMAB-AATY 118 0.0024
7 CARBAMIDE PEROXIDE 1 0.0023
8 ADALIMUMAB-ADAZ 123 0.0022
9 CLEMASTINE FUMARATE 3 0.0022
See all drugs enriched for association with TERMINAL ILEITIS

TERMINAL ILEITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Macrolide Antibacterial [EPC] 8 0.0079
1 Medium-chain Triglyceride [EPC] 1 0.0018
2 Interleukin-23 Antagonist [EPC] 123 0.0012
3 Bile Acid Sequestrant [EPC] 14 0.0011
4 Integrin Receptor Antagonist [EPC] 97 0.0011
5 Endoglycosidase [EPC] 2 0.0011
6 Purine Antimetabolite [EPC] 96 0.0010
7 Vitamin K [EPC] 8 0.0009
8 Somatostatin Analog [EPC] 6 0.0009
9 Anti-coagulant [EPC] 3 0.0008
See all drug classes enriched for association with TERMINAL ILEITIS